Brokerages Set Trupanion, Inc. (NASDAQ:TRUP) Target Price at $41.83

Shares of Trupanion, Inc. (NASDAQ:TRUP) have been assigned an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $44.67.

Several analysts recently weighed in on the company. William Blair initiated coverage on Trupanion in a report on Friday, July 19th. They set an “outperform” rating on the stock. Northland Securities increased their target price on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday. Stifel Nicolaus lifted their price target on shares of Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Bank of America increased their price objective on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research report on Friday, September 20th. Finally, Evercore ISI upgraded Trupanion to a “strong-buy” rating in a research report on Friday, August 9th.

Insider Buying and Selling at Trupanion

In other news, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the transaction, the chief executive officer now directly owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, CEO Margaret Tooth sold 7,500 shares of the stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Fawwad Qureshi sold 640 shares of Trupanion stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $43.12, for a total value of $27,596.80. The disclosure for this sale can be found here. Insiders sold a total of 8,764 shares of company stock valued at $405,238 in the last three months. Company insiders own 5.50% of the company’s stock.

Institutional Investors Weigh In On Trupanion

Several hedge funds have recently modified their holdings of the business. Vanguard Group Inc. raised its stake in Trupanion by 0.9% in the first quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider’s stock worth $101,433,000 after buying an additional 32,485 shares in the last quarter. 8 Knots Management LLC raised its position in shares of Trupanion by 87.0% in the 1st quarter. 8 Knots Management LLC now owns 1,297,485 shares of the financial services provider’s stock worth $35,824,000 after acquiring an additional 603,775 shares in the last quarter. Marshall Wace LLP raised its position in shares of Trupanion by 11.9% in the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after acquiring an additional 116,496 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Trupanion during the 2nd quarter worth $4,739,000. Finally, Dimensional Fund Advisors LP boosted its position in Trupanion by 24.3% during the second quarter. Dimensional Fund Advisors LP now owns 137,833 shares of the financial services provider’s stock valued at $4,052,000 after purchasing an additional 26,941 shares in the last quarter.

Trupanion Stock Performance

Shares of NASDAQ:TRUP opened at $54.78 on Friday. The firm has a fifty day simple moving average of $46.92 and a two-hundred day simple moving average of $36.00. Trupanion has a 52 week low of $19.14 and a 52 week high of $57.90. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $2.31 billion, a P/E ratio of -171.19 and a beta of 1.73.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The company had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. During the same quarter last year, the business posted ($0.10) earnings per share. The firm’s revenue was up 14.6% on a year-over-year basis. On average, analysts expect that Trupanion will post -0.34 earnings per share for the current fiscal year.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.